Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Bioengineering (Basel, Switzerland)
|
October 28, 2023
Three-Dimensional Bioprinting in Soft Tissue Engineering for Plastic and Reconstructive Surgery
Astrid Bülow, Benedikt Schäfer, Justus P Beier
Stem Cells Translational Medicine
|
August 24, 2024
Impact of compression forces on different mesenchymal stem cell types regarding orthodontic indication
Chloé Radermacher, Rogerio B Craveiro, Wilhelm Jahnen-Dechent, et al.
Innovative Surgical Sciences
|
February 18, 2026
Interdisciplinary lower extremity reconstruction in peripheral artery disease with AV-loops and latissimus dorsi flaps
Simon Reß, Anja M Boos, Alexander Gombert, et al.
Frontiers in Pharmacology
|
June 19, 2023
Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
Frontiers in Pharmacology
|
April 3, 2023
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Bioengineering (Basel, Switzerland)
|
October 28, 2023
Three-Dimensional Bioprinting in Soft Tissue Engineering for Plastic and Reconstructive Surgery
Astrid Bülow, Benedikt Schäfer, Justus P Beier
Stem Cells Translational Medicine
|
August 24, 2024
Impact of compression forces on different mesenchymal stem cell types regarding orthodontic indication
Chloé Radermacher, Rogerio B Craveiro, Wilhelm Jahnen-Dechent, et al.
Innovative Surgical Sciences
|
February 18, 2026
Interdisciplinary lower extremity reconstruction in peripheral artery disease with AV-loops and latissimus dorsi flaps
Simon Reß, Anja M Boos, Alexander Gombert, et al.
Frontiers in Pharmacology
|
June 19, 2023
Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
Frontiers in Pharmacology
|
April 3, 2023
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Laura Grohs, Linhan Cheng, Saskia Cönen, et al.
Page
of 1